Is There a Relationship Between Fat‐Free Soft Tissue Mass and Low Cognitive Function? Results From a Study of 7,105 Women
- 5 November 2002
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 50 (11) , 1796-1801
- https://doi.org/10.1046/j.1532-5415.2002.50507.x
Abstract
To test the hypothesis that low fat-free soft tissue mass and cognitive impairment are independently associated. Cross-sectional study. Five geographic areas of France. Seven thousand one hundred five community-dwelling women aged 75 and older recruited from electoral rolls between 1992 and 1994. Fat-free soft tissue mass, body fat mass, and bone mineral density were measured using dual-energy x-ray absorptiometry. Study participants were assessed for cognitive impairment using the Short Portable Mental Status Questionnaire and divided into two groups according to their scores. Logistic regression models were used to calculate multivariate-adjusted differences in body composition between two groups of subjects according to their cognitive function. After adjustment for confounders, compared with women in the highest quartile of fat-free soft tissue mass, women in the lowest quartile had an odds ratio of 1.43 (95% confidence interval (CI) = 1.07-1.91) for cognitive impairment. Low fat mass was also associated with lower cognitive function, with an odds ratio of 1.35 (95% CI = 1.01-1.79) for the lower quartile of fat mass compared with the highest quartile. There was no association between cognitive impairment and bone mineral density. This finding supports the hypothesis that low muscle mass is associated with cognitive impairment in older women. These two components represent major causes of frailty and functional decline in older people and could have some common mechanisms. Nevertheless, these results do not predict the causal variable.Keywords
This publication has 59 references indexed in Scilit:
- Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and FrailtyAnnual Review of Medicine, 2000
- Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?Journal of Neuroimmunology, 2000
- The effect of short-term estrogen replacement therapy on cognition: A randomized, double-blind, cross-over trial in postmenopausal women*1Obstetrics & Gynecology, 1998
- Aging, Memory, and Mild Cognitive ImpairmentInternational Psychogeriatrics, 1997
- Disability as a Public Health Outcome in the Aging PopulationAnnual Review of Public Health, 1996
- What Is Sarcopenia?The Journals of Gerontology: Series A, 1995
- Interventions Based on the Possibility That Oxidative Stress Contributes to SarcopeniaThe Journals of Gerontology: Series A, 1995
- Tobacco consumption and cognitive impairment in elderly people a population-based studyAnnals of Epidemiology, 1994
- Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.Journal of Clinical Investigation, 1994
- Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily LivingThe Gerontologist, 1969